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We report a case of disseminated fatal Talaromyces (Penicillium) marneffei infection in an HIV-infected, antiretroviral treatment-
experienced South African woman who had travelled to mainland China. The 37-year-old woman was admitted to a private 
hospital in fulminant septic shock and died within 12 h of admission. Intracellular yeast-like bodies were observed on the 
peripheral blood smear. A serum cryptococcal antigen test was negative. Blood cultures flagged positive after 2 days; on direct 
microscopy, yeast-like bodies were observed and a thermally dimorphic fungus, confirmed as T. marneffei, was cultured after 
5 days. The clinical features of HIV-associated disseminated penicilliosis overlap with those of tuberculosis and endemic deep 
fungal infections. In the southern African context, where systemic opportunistic fungal infections such as cryptococcosis are 
more common among HIV-infected patients with a CD4+ count of <100 cells/µL, this infection is not likely to be considered in 
the differential diagnosis unless a travel history is obtained. 
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We report a case of disseminated fatal Talaro­
myces (Penicillium) marneffei infection in an 
HIV-infected antiretroviral treatment (ART)-
experienced South African (SA) woman who 
had travelled to mainland China. 
Case
A 37-year-old woman was admitted to a private hospital in 
March 2014 in fulminant septic shock. She was intubated in 
casualty and immediately transferred to the intensive care unit. 
On physical examination, she had marked hepatosplenomegaly, 
and skin lesions resembling those of molluscum contagiosum 
were noted on her face. The patient was prescribed broad-
spectrum antimicrobial therapy on admission, including 
meropenem, high-dose trimethoprim-sulphamethoxazole 
and fluconazole. On admission, her HIV-1 viral load was 
undetectable and her CD4+ T-lymphocyte count was 20 cells/
µL. Details of her travel history, date of HIV diagnosis, ART 
initiation date and ART regimen were unavailable. 
Intracellular yeast-like bodies were observed on the peripheral 
blood smear, which was reported to the treating clinician within 
a few hours. The patient was also anaemic (haemoglobin of 
8.5 g/dL) with marked neutrophilia (17.5 × 109/L), an elevated 
C-reactive protein level (114 mg/L) and elevated liver enzymes 
(alkaline phosphatase 227 U/L; aspartate transaminase 107 U/L). 
The patient died within 12 h of admission. A serum crypto-
coccal antigen test was negative, but the serum (1,3)-β-D-glucan 
level was elevated (112 pg/mL), in keeping with a systemic 
fungal infection. Blood cultures that had been submitted to 
the laboratory were flagged as positive after 2 days. On direct 
microscopy, yeast-like bodies were observed, and a fungus 
was cultured after 5 days. The isolate was referred to the 
National Institute for Communicable Diseases for phenotypic 
and molecular identification. At 25°C, the isolate grew as 
a filamentous mould on Sabouraud agar (Diagnostic Media 
Products (DMP), National Health Laboratory Service (NHLS), 
South Africa). The colony was initially grey-green and then 
turned orange, with a red pigment that readily diffused into the 
agar (Fig. 1A), and had microscopic characteristics consistent 
with T. marneffei. Phase transition to the yeast form was demon-
strated on brain-heart infusion agar after 12 days (DMP, NHLS) 
at 37°C (Fig. 1B). A portion of the internal transcribed spacer 
(ITS) region of the fungal ribosomal RNA gene was sequenced, 
after amplification using ITS1 and ITS4 primers, and the isolate 
was identified as the recently renamed thermally dimorphic 
fungus T. marneffei.[1] 
The potentially fatal systemic infection caused by 
T. marneffei is the third most common AIDS-defining 
opportunistic infection in parts of South-East Asia, where 
this thermally dimorphic fungus is endemic.[2] The clinical 
features of HIV-associated disseminated penicilliosis overlap 
with those of tuberculosis and deep fungal infections such 
as cryptococcosis, histoplasmosis and emmonsiosis; fever, 
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involvement, lymphadenopathy and hepatosplenomegaly are most 
commonly reported.[3] It is possible that this patient developed an 
immune reconstitution inflammatory syndrome related to penicilliosis 
following ART initiation, though this cannot be confirmed.[4] In 
the southern African context, where systemic opportunistic fungal 
infections such as cryptococcosis are far more common among HIV-
infected patients with a CD4+ count <100 cells/µL, this infection is 
not likely to be considered in the differential diagnosis unless a travel 
history is obtained.[5] This is particularly important in cases where 
fluconazole is selected as an empiric antifungal agent instead of 
broader-spectrum agents such as amphotericin B or itraconazole.[6] We 
are aware of only one previously diagnosed case of penicilliosis in SA 
(personal communication with M du Plooy). Hazard Group 3 fungal 
pathogens such as T. marneffei should also be handled with great care 
in diagnostic laboratories. 
References
1. Samson RA, Yilmaz N, Houbraken J, et al. Phylogeny and nomenclature of 
the genus Talaromyces and taxa accommodated in Penicillium subgenus 
Biverticillium. Stud Mycol 2011;70(1):159-183. [http://dx.doi.org/ 10.3114/
sim.2011.70.04] 
2. Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei 
infection and recent advances in the epidemiology and molecular biology aspects. Clin 
Microbiol Rev 2006;19(1):95-110. [http://dx.doi.org/10.1128/CMR.19.1.95-110.2006]
3. Larsson M, Nguyen LH, Wertheim HF, et al. Clinical characteristics and outcome of 
Penicillium marneffei infection among HIV-infected patients in northern Vietnam. 
AIDS Res Ther 2012;9(1):24-29. [http://dx.doi.org/ 10.1186/1742-6405-9-24] 
4. Hall C, Hajjawi R, Barlow G, Thaker H, Adams K, Moss P. Penicillium marneffei 
presenting as an immune reconstitution inflammatory syndrome (IRIS) in a patient 
with advanced HIV. BMJ Case Rep 2013. [http://dx.doi.org/ 10.1136/bcr-2012-007555] 
5. Meiring ST, Quan VC, Cohen C, et al. A comparison of cases of paediatric-
onset and adult-onset cryptococcosis detected through population-based 
surveillance, 2005-2007. AIDS 2012;26(18):2307-2314. [http://dx.doi.org/ 10.1097/
QAD.0b013e3283570567] 
6. Le T, Hong Chau TT, Kim Cuc NT, et al. AIDS-associated Cryptococcus neoformans 
and Penicillium marneffei coinfection: A therapeutic dilemma in resource-limited 
settings. Clin Infect Dis 2010;51(9):e65-e68. [http://dx.doi.org/10.1086/656685] 
Fig. 1. Mould phase of Talaromyces (Penicillium) marneffei on Sabouraud agar (A), and yeast phase of Talaromyces (Penicillium) marneffei on brain-heart 
infusion agar (pale-cream mucoid colonies) (B).
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